| Name / ID | Type | Disease | RRID | Causal gene(s) | Mutation | Originating lab |
|---|---|---|---|---|---|---|
| LUMCi052-C | Cell Lines | SCA7 | CVCL_D6SL |
ATXN7 | 10/60 CAG | Leiden University Medical Center |
| M666T | Cell Lines | SCA28 | — |
AFG3L2 | p.M666T | IRCCS Ospedale San Raffaele |
| MAR-7444-007 | Cell Lines | SACS/ARSACS/SPAX6 | — |
SACS | Protein change: p.Y3430* (Homozygous variant) | University of Bordeaux |
| MBP-α-Syn transgenic mouse | Mouse Models | MSA/OPCA | — |
Sporadic | human α-synuclein cDNA | University of California |
| MCRIi025-A | Cell Lines | CANVAS | CVCL_D0HT |
RFC1 | Disease | Murdoch Children's Research Institute, University of Melbourne |
| MCRIi025-B | Cell Lines | CANVAS | CVCL_D0HU |
RFC1 | Control | Murdoch Children's Research Institute, University of Melbourne |
| MCRIi026-A | Cell Lines | CANVAS | CVCL_D0HV |
RFC1 | Disease | Murdoch Children's Research Institute, University of Melbourne |
| MCRIi026-B | Cell Lines | CANVAS | CVCL_D0HW |
RFC1 | Control | Murdoch Children's Research Institute, University of Melbourne |
| MCRIi027-A | Cell Lines | CANVAS | CVCL_D0HX |
RFC1 | Disease | Murdoch Children's Research Institute, University of Melbourne |
| MCRIi027-B | Cell Lines | CANVAS | CVCL_D0HY |
RFC1 | Control | Murdoch Children's Research Institute, University of Melbourne |
| MJD iPSC | Cell Lines | SCA3 | — |
ATXN3 | 18/79 CAG | University of Coimbra |
| MJD1-9,11 | Cell Lines | SCA3 | CVCL_W571, CVCL_W570 |
ATXN3 | 74/22 CAG | University of Bonn and Hertie Foundation |
| MJD2-2,9 | Cell Lines | SCA3 | CVCL_W572, CVCL_W573 |
ATXN3 | 74/21 CAG | University of Bonn and Hertie Foundation |
| MJD3-5 | Cell Lines | SCA3 | CVCL_W574 |
ATXN3 | 73/27 CAG | University of Bonn and Hertie Foundation |
| MJD4-1 | Cell Lines | SCA3 | CVCL_W575 |
ATXN3 | 73/20 CAG | University of Bonn and Hertie Foundation |
| MSA-1 | Cell Lines | MSA/OPCA | CVCL_E3CN, CVCL_E3CZ |
? | — | Brigham and women's Hospital |
| MSA-10 | Cell Lines | MSA/OPCA | CVCL_E3CR |
? | — | Brigham and women's Hospital |
| MSA-12 | Cell Lines | MSA/OPCA | CVCL_E3CS |
? | — | Brigham and women's Hospital |
| MSA-16 | Cell Lines | MSA/OPCA | CVCL_E3CT |
? | — | Brigham and women's Hospital |
| MSA-17 | Cell Lines | MSA/OPCA | CVCL_E3CU |
? | — | Brigham and women's Hospital |
| MSA-20 | Cell Lines | MSA/OPCA | CVCL_E3CV, CVCL_E3D1 |
? | — | Brigham and women's Hospital |
| MSA-21 | Cell Lines | MSA/OPCA | CVCL_E3CW, CVCL_E3D2 |
? | — | Brigham and women's Hospital |
| MSA-22 | Cell Lines | MSA/OPCA | CVCL_E3CX |
? | — | Brigham and women's Hospital |
| MSA-23 | Cell Lines | MSA/OPCA | CVCL_E3CY, CVCL_E3D3 |
? | — | Brigham and women's Hospital |
| MSA-5 | Cell Lines | MSA/OPCA | CVCL_E3CP, CVCL_E3D0 |
? | — | Brigham and women's Hospital |
| MSA-6 | Cell Lines | MSA/OPCA | CVCL_E3CQ |
? | — | Brigham and women's Hospital |
| MSA-A26, A31, A34 (MSA-C) | Cell Lines | MSA/OPCA | — |
? | COQ2 mutation exon 7 c.[1159C > T]; [1178T > C] p. [R387*]; [V393A] | University of Tokyo/Keio University School of Medicine |
| MSA-Awt5, Awt9, Awt11 | Cell Lines | MSA/OPCA | — |
? | COQ2 mutation corrected with CRISPR/Cas9 from MSA-A26 | University of Tokyo/Keio University School of Medicine |
| MSA-B1, B2, B3 (MSA-C) | Cell Lines | MSA/OPCA | — |
? | — | University of Tokyo/Keio University School of Medicine |
| MSA-C, patient 4 | Cell Lines | MSA/OPCA | — |
? | — | Lund University |
| MSA-C1 | Cell Lines | MSA/OPCA | — |
? | — | University of Milan |
| MSA-C2 | Cell Lines | MSA/OPCA | — |
? | — | University of Milan |
| MSA-C3 | Cell Lines | MSA/OPCA | — |
? | — | University of Milan |
| MSA-C4 | Cell Lines | MSA/OPCA | — |
? | — | University of Milan |
| MSA-C5 | Cell Lines | MSA/OPCA | — |
? | — | University of Milan |
| MSA-C6 | Cell Lines | MSA/OPCA | — |
? | — | University of Milan |
| MSA-C7 | Cell Lines | MSA/OPCA | — |
? | — | University of Milan |
| MSA-P | Cell Lines | MSA/OPCA | — |
? | — | Barcelona Institute for Science and Technology |
| MSA-P, patient 6 | Cell Lines | MSA/OPCA | — |
? | — | Lund University |
| MSA-P1 | Cell Lines | MSA/OPCA | — |
? | — | University of Milan |
| MSA-P2 | Cell Lines | MSA/OPCA | — |
? | — | University of Milan |
| MSA-P2 (probable MSA-P) | Cell Lines | MSA/OPCA | — |
? | — | Hannover Medical School |
| MSA-P3 | Cell Lines | MSA/OPCA | — |
? | — | University of Milan |
| MSA-P3 (probable MSA-P) | Cell Lines | MSA/OPCA | — |
? | — | Hannover Medical School |
| MSA-P4 | Cell Lines | MSA/OPCA | — |
? | — | University of Milan |
| MSA-P5 | Cell Lines | MSA/OPCA | — |
? | — | University of Milan |
| MSA-P6 | Cell Lines | MSA/OPCA | — |
? | — | University of Milan |
| MSA-P7 | Cell Lines | MSA/OPCA | — |
? | — | University of Milan |
| MSA1 P | Cell Lines | MSA/OPCA | — |
? | — | Medical University of Innsbruck |
| MSA2 P | Cell Lines | MSA/OPCA | — |
? | — | Medical University of Innsbruck |
Twenty Twenty-Five
Designed with WordPress